Tafamidis meglumine
Product Specifications
CAS Number
951395-08-7
Synonyms
Vyndaqel, Fx-1006A
Target
Others
Applications
Others
Molecular Formula
C14H7Cl2NO3.C7H17NO5
Additionnal Information
Tafamidis meglumine (Vyndaqel, Fx-1006A) stabilizes the tetrameric structure of transthyretin (TTR) by binding to thyroxine-binding sites. Tafamidis meglumine treats transthyretin familial amyloid polyneuropathies (TTR-FAP), a condition characterized by neurological damage from TTR amyloidosis, by preventing the misfolding and aggregation of transthyretin (TTR) into amyloid fibrils.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941865-100 1x 100 µL
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1865R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941422-500 1x 500 µL
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (NX2/1422R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details